BIODESIX INC — Director's Dealing 2024

May 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2024-05-21

Reporting Person: Strobeck Matthew (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-23	Common Stock	M	52160	—	Acquired	85673	Indirect
2024-05-23	Common Stock	M	295680	—	Acquired	2570879	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-05-21	Restricted Stock Units	$	A	53726	Acquired		Common Stock (53726)	Direct
2024-05-21	Stock Options (Right to Buy)	$1.57	A	37050	Acquired	2034-05-20	Common Stock (37050)	Direct
2024-05-23	Series A Non-Voting Convertible Preferred Stock	$	M	1304	Disposed		Common Stock (52160)	Indirect
2024-05-23	Series A Non-Voting Convertible Preferred Stock	$	M	7392	Disposed		Common Stock (295680)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2542928	Direct
Common Stock	119003	Indirect
Common Stock	119003	Indirect
Common Stock	119003	Indirect
Common Stock	119003	Indirect
Common Stock	40665	Indirect

Footnotes

F1: The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.

F2: The Reporting Person has sole voting and dispositive power with respect to shares held by each of Birchview Fund LLC and the Birchview Capital Separately Managed Account in his capacity as Manager of such entities. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F3: The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F4: The Reporting Person is an affiliate of Clajer Capital LLC. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F5: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.

F6: These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.

F7: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.

F8: This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.